SNTS - Maybe to be sold - New 8k (New exec employment amendments)
New employment agreements in 8k report this . Very suspicious to be done before end of year . Why now before a PDUFA date.... Also, $2.0m purchase by Director. #$%$. He didn't buy at $3.00 and buys at $11...
Something fishy going on..... Lets hope we get taken out...
If it happens, it happens before JPM conference.
I think you are onto something. When is the JPM conference? If Uceris is approved and also Rhuconest on the way who would not want to take this out along with the 4 other drugs on the market. I saw SEPR taken over by a Japanese company that wanted products and a US sales force. Looks like the Bosses are preparing a nice exit strategy, or planning for a possible take-over with the new arrangement. Who (what insider) would buy now at $10.88 without hoping for a nice gain (my guess would be at least a 50% gain or $1 million in this case). He (and they) know the risks and probability for success better than the public.
I have been wondering if this preliminary labeling by FDA is practically an approval. I have never seen this before, but I am not that old. It seems positive to me.
All of these things make this a very hot stock. It will go higher with pullbacks along the way. JMO